BSE filing, NSE: SARDAPPR. Summary written from the filing by ALFA Finder's alert engine.
Tahmar Enterprises Ltd: key numbers
- Share price
- ₹3.92
- Market cap
- ₹61.07 Cr
- Revenue (annual)
- ₹2.59 Cr
- Net profit (annual)
- ₹-5.60 Cr
- P/E (TTM)
- -14.4×Sector 26.8×
- Promoter holding
- 65.86%+0.00% QoQ
- FII holding
- 0.03%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Tahmar Enterprises Ltd
All →Tahmar Enterprises Management Change
Ms. Kanika Kabra has resigned as an Independent Director of Tahmar Enterprises Ltd, effective October 16, 2026, due to other professional commitments.
Tahmar Enterprises Other Announcement
Tahmar Enterprises Limited filed the quarterly compliance certificate under Regulation 74(5) of SEBI (DP) Regulations, 2018, as received from its RTA, MUFG Intime India Private Limited.
Tahmar Enterprises Annual General Meeting
Tahmar Enterprises Ltd held its 35th Annual General Meeting on September 29, 2026. Shareholders adopted the annual financial statements and approved the proposed related party transactions.
Tahmar Enterprises Product Launch
Tahmar Enterprises approved entering the manufacture of Indian Made Foreign Liquor and Maharashtra Made Liquor at its existing distillery, with brand registration steps to follow.
Tahmar Enterprises Price Movement Clarification
Tahmar Enterprises replied to BSE's price-movement query, confirming no undisclosed information exists. The company stated the share price movement is purely market-driven.
Tahmar Enterprises Regulatory Approval
Tahmar Enterprises received regulatory approval from the Maharashtra State Excise Department to manufacture Indian Made Foreign Liquor (IMFL) at its Kolhapur distillery.
- Value
- ₹0.34 Cr
Other other announcement announcements
All →Aarti Pharmalabs Other Announcement
Aarti Pharmalabs has intimated under Regulation 46 that it revamped its website at the existing URL to improve design and accessibility. The notice has no financial or business substance.
Sagarsoft (India) Other Announcement
Sagarsoft (India) filed its Regulation 32 fund utilisation statement for its 2021 preferential issue. No deviation was reported and the full Rs.5.08 Crore was used.
Sadhana Nitro Chem Other Announcement
Sadhana Nitro Chem reported no deviation in use of its preferential issue proceeds for the quarter ended September 2026. The Audit Committee reviewed the statement.
Shriram Asset Management Company Other Announcement
Shriram AMC filed ICRA's quarterly monitoring agency report on preferential issue proceeds. Utilisation is in line with the offer objects, with no deviation reported.
Jhandewalas Foods Other Announcement
Jhandewalas Foods filed its quarterly shareholding pattern for the period ended September 30, 2026. The filing records holdings by category and contains no transaction or money event.
Avience Biomedicals Other Announcement
Avience Biomedicals confirmed corporate governance compliance is not applicable, as it is SME-listed on NSE Emerge. No quarterly governance report is required for September 2026.